Your browser doesn't support javascript.
loading
Genotype-phenotype correlations and novel molecular insights into the DHX30-associated neurodevelopmental disorders.
Mannucci, Ilaria; Dang, Nghi D P; Huber, Hannes; Murry, Jaclyn B; Abramson, Jeff; Althoff, Thorsten; Banka, Siddharth; Baynam, Gareth; Bearden, David; Beleza-Meireles, Ana; Benke, Paul J; Berland, Siren; Bierhals, Tatjana; Bilan, Frederic; Bindoff, Laurence A; Braathen, Geir Julius; Busk, Øyvind L; Chenbhanich, Jirat; Denecke, Jonas; Escobar, Luis F; Estes, Caroline; Fleischer, Julie; Groepper, Daniel; Haaxma, Charlotte A; Hempel, Maja; Holler-Managan, Yolanda; Houge, Gunnar; Jackson, Adam; Kellogg, Laura; Keren, Boris; Kiraly-Borri, Catherine; Kraus, Cornelia; Kubisch, Christian; Le Guyader, Gwenael; Ljungblad, Ulf W; Brenman, Leslie Manace; Martinez-Agosto, Julian A; Might, Matthew; Miller, David T; Minks, Kelly Q; Moghaddam, Billur; Nava, Caroline; Nelson, Stanley F; Parant, John M; Prescott, Trine; Rajabi, Farrah; Randrianaivo, Hanitra; Reiter, Simone F; Schuurs-Hoeijmakers, Janneke; Shieh, Perry B.
Afiliação
  • Mannucci I; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
  • Dang NDP; Department of Pharmacology and Toxicology, University of Alabama, Birmingham, USA.
  • Huber H; Department of Biochemistry, Theodor Boveri Institute, Biocenter of the University of Würzburg, 97070, Würzburg, Germany.
  • Murry JB; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Abramson J; UCLA Clinical Genomics Center, University of California Los Angeles, Los Angeles, CA, USA.
  • Althoff T; Department of Physiology, University of California Los Angeles, Los Angeles, CA, USA.
  • Banka S; Department of Physiology, University of California Los Angeles, Los Angeles, CA, USA.
  • Baynam G; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
  • Bearden D; Division of Evolution & Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Beleza-Meireles A; Faculty of Medicine and Health Sciences, University of Western Australia, Perth, WA, Australia.
  • Benke PJ; Western Australian Register of Developmental Anomalies, King Edward Memorial Hospital, Perth, Australia.
  • Berland S; Telethon Kids Institute, Perth, Australia.
  • Bierhals T; Division of Child Neurology, Department of Neurology, University of Rochester School of Medicine, Rochester, NY, USA.
  • Bilan F; Clinical Genetics Department, University Hospitals Bristol and Weston, Bristol, UK.
  • Bindoff LA; Joe DiMaggio Children's Hospital, Hollywood, FL, USA.
  • Braathen GJ; Department of Medical Genetics, Haukeland University Hospital, 5021, Bergen, Norway.
  • Busk ØL; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
  • Chenbhanich J; Department of Medical Genetics, Centre Hospitalier Universitaire de Poitiers, Poitiers, France.
  • Denecke J; Laboratoire de Neurosciences Cliniques et Expérimentales-INSERM U1084, Université de Poitiers, Poitiers, France.
  • Escobar LF; Department of Clinical Medicine (K1), University of Bergen, Bergen, Norway.
  • Estes C; Department of Neurology, Haukeland University Hospital, Bergen, Norway.
  • Fleischer J; Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.
  • Groepper D; Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.
  • Haaxma CA; Division of Medical Genetics, Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.
  • Hempel M; Department of Pediatrics, University Medical Center Eppendorf, 20246, Hamburg, Germany.
  • Holler-Managan Y; Peyton Manning Children's Hospital, Ascension Health, Indianapolis, IN, USA.
  • Houge G; Peyton Manning Children's Hospital, Ascension Health, Indianapolis, IN, USA.
  • Jackson A; Department of Pediatrics, Southern Illinois University School of Medicine, Springfield, IL, 62702, USA.
  • Kellogg L; Department of Pediatrics, Southern Illinois University School of Medicine, Springfield, IL, 62702, USA.
  • Keren B; Department of Pediatric Neurology, Amalia Children's Hospital and Donders Institute for Brain, Cognition and Behavior, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
  • Kiraly-Borri C; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
  • Kraus C; Division of Neurology, Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Kubisch C; Department of Medical Genetics, Haukeland University Hospital, 5021, Bergen, Norway.
  • Le Guyader G; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK.
  • Ljungblad UW; Division of Evolution & Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Brenman LM; Kaiser Permanente Sacramento, Sacramento, USA.
  • Martinez-Agosto JA; Département de Génétique, Hôpital La Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Might M; Genetic Services of Western Australia, Perth, Western Australia, 6008, Australia.
  • Miller DT; Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054, Erlangen, Germany.
  • Minks KQ; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
  • Moghaddam B; Department of Medical Genetics, Centre Hospitalier Universitaire de Poitiers, Poitiers, France.
  • Nava C; Laboratoire de Neurosciences Cliniques et Expérimentales-INSERM U1084, Université de Poitiers, Poitiers, France.
  • Nelson SF; Department of Pediatrics, Vestfold Hospital, 3116, Tønsberg, Norway.
  • Parant JM; Department of Genetics, Kaiser Permanente Northern California, Oakland, USA.
  • Prescott T; UCLA Clinical Genomics Center, University of California Los Angeles, Los Angeles, CA, USA.
  • Rajabi F; Semel Institute of Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA, USA.
  • Randrianaivo H; Department of Pediatrics, Division of Medical Genetics at David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Reiter SF; Department of Human Genetics at David Geffen School of Medicine University of California Los Angeles, Los Angeles, CA, USA.
  • Schuurs-Hoeijmakers J; Department of Medicine, Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham, 510 20th St S, Birmingham, AL, 35210, USA.
  • Shieh PB; Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA, USA.
Genome Med ; 13(1): 90, 2021 05 21.
Article em En | MEDLINE | ID: mdl-34020708
ABSTRACT

BACKGROUND:

We aimed to define the clinical and variant spectrum and to provide novel molecular insights into the DHX30-associated neurodevelopmental disorder.

METHODS:

Clinical and genetic data from affected individuals were collected through Facebook-based family support group, GeneMatcher, and our network of collaborators. We investigated the impact of novel missense variants with respect to ATPase and helicase activity, stress granule (SG) formation, global translation, and their effect on embryonic development in zebrafish. SG formation was additionally analyzed in CRISPR/Cas9-mediated DHX30-deficient HEK293T and zebrafish models, along with in vivo behavioral assays.

RESULTS:

We identified 25 previously unreported individuals, ten of whom carry novel variants, two of which are recurrent, and provide evidence of gonadal mosaicism in one family. All 19 individuals harboring heterozygous missense variants within helicase core motifs (HCMs) have global developmental delay, intellectual disability, severe speech impairment, and gait abnormalities. These variants impair the ATPase and helicase activity of DHX30, trigger SG formation, interfere with global translation, and cause developmental defects in a zebrafish model. Notably, 4 individuals harboring heterozygous variants resulting either in haploinsufficiency or truncated proteins presented with a milder clinical course, similar to an individual harboring a de novo mosaic HCM missense variant. Functionally, we established DHX30 as an ATP-dependent RNA helicase and as an evolutionary conserved factor in SG assembly. Based on the clinical course, the variant location, and type we establish two distinct clinical subtypes. DHX30 loss-of-function variants cause a milder phenotype whereas a severe phenotype is caused by HCM missense variants that, in addition to the loss of ATPase and helicase activity, lead to a detrimental gain-of-function with respect to SG formation. Behavioral characterization of dhx30-deficient zebrafish revealed altered sleep-wake activity and social interaction, partially resembling the human phenotype.

CONCLUSIONS:

Our study highlights the usefulness of social media to define novel Mendelian disorders and exemplifies how functional analyses accompanied by clinical and genetic findings can define clinically distinct subtypes for ultra-rare disorders. Such approaches require close interdisciplinary collaboration between families/legal representatives of the affected individuals, clinicians, molecular genetics diagnostic laboratories, and research laboratories.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / RNA Helicases / Estudos de Associação Genética / Transtornos do Neurodesenvolvimento Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Genome Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Predisposição Genética para Doença / RNA Helicases / Estudos de Associação Genética / Transtornos do Neurodesenvolvimento Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Genome Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
...